What is Figure 1?
Founded in 2013 and headquartered in Toronto, Canada, Figure 1 operates as a mobile-first network designed to enable healthcare professionals globally to view and share medical cases. This platform facilitates knowledge exchange and collaboration among physicians and other medical practitioners, enhancing diagnostic capabilities and patient care through a digital medium. The company's focus on a mobile-first approach ensures accessibility and ease of use for its user base, positioning it as a key player in the evolving landscape of medical communication and education.
How much funding has Figure 1 raised?
Figure 1 has raised a total of $19.5M across 4 funding rounds:
Angel/Seed
$2M
Private Equity
$2.5M
Series A
$5M
Series B
$10M
Angel/Seed (2013): $2M with participation from Investment Accelerator Fund, Version One Ventures, Ryerson Futures Inc., and Rho Canada Ventures
Private Equity (2015): $2.5M, investors not publicly disclosed
Series A (2015): $5M supported by Union Square Ventures, Allen & Company, Version One Ventures, and Rho Canada Ventures
Series B (2017): $10M featuring Western Technology Investment, Union Square Ventures, Samsung NEXT, Version One Ventures, Kensington Capital Partners, Hedgewood, Rho Canada Ventures, and John Hancock
Key Investors in Figure 1
Union Square Ventures
Union Square Ventures is a New York City-based venture capital firm that invests in transformative markets influenced by technological and societal changes, focusing on innovative companies poised for growth.
Version One Ventures
Version One Ventures is an early-stage venture fund that invests in mission-driven founders in emerging markets, dedicated to supporting bold entrepreneurs with innovative ideas.
Rho Canada Ventures
Rho Canada Ventures is a venture capital firm that has been investing in innovation since 1981, focusing on companies at various stages of growth and providing strategic value through extensive experience.
What's next for Figure 1?
With substantial backing, including its most recent major strategic investment, Figure 1 is poised for accelerated expansion and further innovation. The enterprise-level funding suggests a strategic focus on scaling operations, enhancing platform features, and potentially broadening its market reach. This capital infusion will likely support the company's efforts to solidify its position as a leading platform for medical case sharing and professional development, enabling it to tackle new challenges and opportunities within the global healthcare technology industry. The company's trajectory indicates a strong emphasis on leveraging technology to improve medical collaboration and outcomes.
See full Figure 1 company page
